Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐ and long‐term outcome in high‐risk children with COVID‐19.

MLA

Wu, Jheng‐Yan, et al. “Clinical Effectiveness of Nirmatrelvir plus Ritonavir on the Short‐ and Long‐term Outcome in High‐risk Children with COVID‐19.” Journal of Medical Virology, vol. 96, no. 5, May 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1002/jmv.29662.

APA

Wu, J., Chen, C., Liu, M., Hsu, W., Tsai, Y., Liu, T., Pin, C. S., Huang, P., Chuang, M., Lee, M., Hung, K., Yu, T., & Lai, C. (2024). Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐ and long‐term outcome in high‐risk children with COVID‐19. Journal of Medical Virology, 96(5), 1–9. https://doi.org/10.1002/jmv.29662

Chicago

Wu, Jheng‐Yan, Chia‐Chen Chen, Mei‐Yuan Liu, Wan‐Hsuan Hsu, Ya‐Wen Tsai, Ting‐Hui Liu, Chien, Sung Pin, et al. 2024. “Clinical Effectiveness of Nirmatrelvir plus Ritonavir on the Short‐ and Long‐term Outcome in High‐risk Children with COVID‐19.” Journal of Medical Virology 96 (5): 1–9. doi:10.1002/jmv.29662.